Vanguard Personalized Indexing Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
194,028
+31,712
| +20% | +$3.52M | 0.24% | 64 |
|
|
2025
Q1 | $18.2M | Buy |
162,316
+12,099
| +8% | +$1.36M | 0.27% | 59 |
|
|
2024
Q4 | $13.9M | Buy |
150,217
+9,316
| +7% | +$861K | 0.21% | 74 |
|
|
2024
Q3 | $11.8M | Buy |
140,901
+34,995
| +33% | +$2.93M | 0.19% | 87 |
|
|
2024
Q2 | $7.26M | Sell |
105,906
-2,763
| -3% | -$189K | 0.14% | 120 |
|
|
2024
Q1 | $7.96M | Sell |
108,669
-2,876
| -3% | -$211K | 0.17% | 99 |
|
|
2023
Q4 | $9.04M | Sell |
111,545
-229
| -0.2% | -$18.6K | 0.23% | 68 |
|
|
2023
Q3 | $8.38M | Buy |
111,774
+15,889
| +17% | +$1.19M | 0.25% | 60 |
|
|
2023
Q2 | $7.39M | Buy |
95,885
+9,015
| +10% | +$695K | 0.23% | 72 |
|
|
2023
Q1 | $7.21M | Buy |
86,870
+9,540
| +12% | +$791K | 0.25% | 67 |
|
|
2022
Q4 | $6.64M | Buy |
77,330
+8,080
| +12% | +$694K | 0.27% | 59 |
|
|
2022
Q3 | $4.27M | Buy |
69,250
+17,577
| +34% | +$1.08M | 0.19% | 87 |
|
|
2022
Q2 | $3.19M | Buy |
51,673
+22,326
| +76% | +$1.38M | 0.15% | 122 |
|
|
2022
Q1 | $1.74M | Sell |
29,347
-4,016
| -12% | -$239K | 0.08% | 227 |
|
|
2021
Q4 | $2.42M | Buy |
33,363
+4,363
| +15% | +$317K | 0.14% | 123 |
|
|
2021
Q3 | $2.03M | Buy |
29,000
+4,806
| +20% | +$336K | 0.18% | 107 |
|
|
2021
Q2 | $1.67M | Buy |
24,194
+6,889
| +40% | +$474K | 0.17% | 118 |
|
|
2021
Q1 | $1.12M | Buy |
17,305
+5,357
| +45% | +$346K | 0.17% | 126 |
|
|
2020
Q4 | $696K | Buy |
11,948
+1,082
| +10% | +$63K | 0.15% | 156 |
|
|
2020
Q3 | $687K | Buy |
10,866
+382
| +4% | +$24.2K | 0.19% | 127 |
|
|
2020
Q2 | $807K | Buy |
10,484
+884
| +9% | +$68K | 0.37% | 57 |
|
|
2020
Q1 | $718K | Buy |
+9,600
| New | +$718K | 0.42% | 64 |
|